Navigation Links
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
Date:4/29/2013

lease contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, we are using forward-looking statements when we discuss how the results of our study demonstrate that our technology effectively delivers insulin without compromising its bioactivity, and serve as an impetus to realize the therapeutic potential of ORMD-0801 in regulating T1DM, or when we discuss our oral insulin and oral exenatide candidates approaching Phase 2 clinical trials under U.S. IND and 2a clinical trials, respectively. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval

or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
2. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
3. Oramed Submits New IND Application for Oral Insulin Trial in the US
4. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
5. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
8. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
9. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
10. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
11. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  A substantial ... make decisions about which therapies are included in ... placement, according to a new Manhattan Research study, ... . The study finds that P&T committee members ... benefits managers (PBMs) have set a high bar ...
(Date:7/31/2014)... -- For its innovative modular Biomedical Research building in ... has earned a Modular Building Institute (MBI) 2014 Award ... categories, MBI,s contest is the commercial modular industry,s premier ... dealers, and product and service providers. ... our team," said Dan Palmer , President of ...
(Date:7/31/2014)... CHICAGO , July 31, 2014  Zacks.com announces the ... the Zacks Equity Research analysts discuss the latest news and ... in the blog include the Biogen (Nasdaq: BIIB - Free ... Puma Biotechnology (NYSE: PBYI - Free Report ), AbbVie ... CELG - Free Report ). Today, Zacks ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... FRANCISCO, Feb. 28, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... Gower, the company,s chairman and chief executive officer, is ... conferences during the month of March.  Details of each ... March 2nd at 1:30 p.m. ETLocation:  New York, NY ...
... Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or ... marketing and sale of medical devices and homecare medical ... The Piacente Group ("TPG"), a full-service investor relations firm ... support the Company,s increased investor relations efforts. ...
Cached Medicine Technology:Rigel to Present at Three Upcoming Investor Conferences 2Dehaier Medical Retains The Piacente Group as Strategic Investor Relations Consulting Firm 2Dehaier Medical Retains The Piacente Group as Strategic Investor Relations Consulting Firm 3
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 The ... moves the lower jaw forward to help open a snorers airway ... VitalSleep anti-snoring remedy helped her relationship with her husband ... "I am a 46 years old. My snoring began about 15 ... that my husband and children could not sleep and had to ...
(Date:7/31/2014)... 2014 Today, Good Neighbor Pharmacy ... patient care by kicking off another year of ... first of many education sessions and initiatives took ... Good Neighbor Pharmacy and AmerisourceBergen’s annual conference. Sessions ... (CMS) Star Measures were a highlight and helped ...
(Date:7/31/2014)... 31, 2014 Live To Be ... trained counselors provide guidance, advice and program information to ... their battle against drug or alcohol addiction, proudly announced ... with Jared Blake: country music’s bad boy, gone good. ... a recovering alcoholic,” commented Blake, whose new single Stomp ...
(Date:7/31/2014)... July 31, 2014 Clifton Dental Associates ... application of topical fluoride treatments to their adult patients ... help with tooth sensitivity in patients that exhibit symptoms. ... infection that is commonly known as “tooth decay” or ... of the teeth. , Fluoride therapy is ...
(Date:7/31/2014)... Carnegie Mellon University have developed a novel method ... of fibers found in living cells. The work ... for drug delivery and tissue engineering applications. The ... of Angewandte Chemie International Edition . , ... to protein molecules, we can form completely new ...
Breaking Medicine News(10 mins):Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 2Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:Carnegie Mellon chemists create nanofibers using unprecedented new method 2
... John Griffin, Jim Reynolds, MD join executive team; Jerry Noyce announces ... ... Feb. 4 HealthFitness (OTC,Bulletin Board: HFIT) announced today that John ... has joined the,company as chief medical officer and Jerry Noyce has ...
... Sharps Disposal by Mail System(R) and other products reach $3.8 million; ... growth in pharmaceutical and hospitality markets - Strong operating leverage shows ... thousand also expected in third ... quarter fiscal 2008, - Purchase ...
... Lifesaving Grants To Improve Pediatric Emergency Care ... ... charitable,organization dedicated to reducing the high level of infant mortality in,the United States, ... happy to announce five new hospital programs that,received grants in January 2008 totaling ...
... Symposium Focuses on Improving Drought Tolerance, DES ... the world convened here today for a three-day ... plants. Hosted by DuPont,(NYSE: DD ) business ... share,research information among public and private organizations in ...
... Beryl Companies announced today the,appointment of marketing ... communications. In this role, she will oversee ... working closely,with sales, customer relations and product ... in marketing communications,research and operations in both ...
... found it lowered pain scores by more than 78% , , ... sugar helps the medicine go down, a new study shows ... experts are hoping that a simple sugar-and-water solution will also ... "We,re hoping this will encourage parents to get their children ...
Cached Medicine News:Health News:HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires 2Health News:HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires 3Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 2Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 3Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 4Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 5Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 6Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 7Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 8Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 9Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 10Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 11Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 12Health News:R Baby Foundation Raises $2.5 Million in First Year 2Health News:R Baby Foundation Raises $2.5 Million in First Year 3Health News:R Baby Foundation Raises $2.5 Million in First Year 4Health News:DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity 2Health News:Sugar Water Eases Pain of Infant Vaccinations 2Health News:Sugar Water Eases Pain of Infant Vaccinations 3